X

Rubriques :

Maroc - PHARMABIZ.COM - A la Une - 27/Jun 00:00

CDR─Life expands pipeline of highly cancer─specific targeted therapies

CDR─Life Inc, a global company developing powerful T─cell engagers (TCE) to eradicate hard─to─treat solid tumors, has announced an expansion of its pipeline of novel T cell engagers (TCE) with the addition of

Articles similaires

B-Cell Lymphoma Clinical Trials Analysis 2024: FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration, and Companies by DelveInsight

mountaintoday.in - 05/Jul 07:12

B-Cell Lymphoma Pipeline (Albany, United States) As per DelveInsight’s assessment, globally, B-Cell Lymphoma pipeline constitutes 160+ key companies...

Exploring Breast Cancer Stages: A Guide to Understanding the Classification System

popdiaries.com - 28/Jun 11:43

Breast cancer is a complex disease with varying degrees of severity and treatment approaches. Central to understanding and managing breast cancer is...

FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder

zacks.com - 24/Jun 14:19

Per argenx (ARGX), the label expansion to Vyvgart Hytrulo makes it the first FDA-approved medication with a novel mechanism of action to treat chronic...

PD-1 Non-Small Cell Lung Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:16

DelveInsight’s, “PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline Insight 2024” report provides comprehensive...

Novel inhibitor HVH-2930 showing promise in overcoming trastuzumab resistance in HER2-positive breast cancer

oncologynews.com.au - 02/Jul 15:29

HER2-positive breast cancer, known for its aggressive nature due to the overexpression of the HER2 protein, poses significant challenges in treatment....

University of Nebraska Medical Center enrolls patient for RenovoRx's pivotal phase III TIGeR─PaC trial

pharmabiz.com - 28/Jun 00:00

RenovoRx, Inc, a clinical─stage biopharmaceutical company developing novel precision oncology therapies based on a local drug─delivery platform,...

Advanced Merkel Cell Carcinoma Pipeline 2024 | Xencor, Inc., Incyte Corporation, Millennium Pharmaceuticals, Inc., Exelixis, Bristol-Myers Squibb, bluebird bio, Affini-T Therapeutics

mountaintoday.in - 04/Jul 18:08

DelveInsight’s, “Advanced Merkel cell carcinoma Pipeline Insight 2024” report provides comprehensive insights...

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma

zacks.com - 27/Jun 15:03

Following the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to treat relapsed/refractory (R/R) follicular...

Lupus Nephritis Pipeline Insights 2024: Therapies, Clinical Trials by DelveInsight | Roche, Equillium, BeiGene, Janssen R&D, Horizon Therapeutics, Novartis, Roche, AstraZeneca

mountaintoday.in - 05/Jul 09:32

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Lupus Nephritis pipeline constitutes 20+ key companies continuously...

Research paves way for new forms of immunotherapy to treat people with Merkel cell cancer

news.medical.net - 01/Jul 13:41

Scientists behind a new type of immunotherapy are demonstrating significant effects in laboratory experiments in cell samples from patients with the...

Les derniers communiqués

Aucun élément